nasopharyngeal-carcinoma

Documents about nasopharyngeal-carcinoma

• Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma#442093ClinicalTrials.gov
• A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma#846316ClinicalTrials.gov
• To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma#903391ClinicalTrials.gov
• Impact on Xerostomia for Nasopharyngeal Carcinoma Patients Treated With or Without Superficial Parotid Lobe-sparing Intensity-modulated Radiotherapy#914407ClinicalTrials.gov
• Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma#915298ClinicalTrials.gov
• Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma#842486ClinicalTrials.gov
• Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma#846868ClinicalTrials.gov
• Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma#864100ClinicalTrials.gov
• A Study of BL-M08D1 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma and Other Solid Tumors#872876ClinicalTrials.gov
• TPC VS. GP Induced Chemotherapy Combined With Nimotuzumab and Toripalimab in the Treatment of Locally Advanced Nasopharyngeal Carcinoma#885206ClinicalTrials.gov
• Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients#898415ClinicalTrials.gov
• Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma#148754ClinicalTrials.gov
• Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma#683091ClinicalTrials.gov
• To Evaluate Transoral Flexible Endoscope With Narrow Band Imaging in Nasopharyngeal Cancer#895328ClinicalTrials.gov
• PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients#883252ClinicalTrials.gov
• Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma#913865ClinicalTrials.gov
• Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)#911325ClinicalTrials.gov
• Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma#256892ClinicalTrials.gov
• IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal Carcinoma#866543ClinicalTrials.gov
• Umbrella Biomarker-Guided Therapy in NPC#405151ClinicalTrials.gov
• Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma#825820ClinicalTrials.gov
• Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT#868051ClinicalTrials.gov
• Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma#802570ClinicalTrials.gov
• PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial#806839ClinicalTrials.gov
• To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma#866021ClinicalTrials.gov
• Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical Trail#888148ClinicalTrials.gov
• Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma#966851ClinicalTrials.gov
• A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma#969601ClinicalTrials.gov
• A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors#640573ClinicalTrials.gov
• De-identified analysis dataset for pretreatment EBV-DNA/TLG risk stratification in non-metastatic nasopharyngeal carcinoma#433176Figshare
• Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)#811098ClinicalTrials.gov
• The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients#811397ClinicalTrials.gov
• Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma#893765ClinicalTrials.gov
• TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma#325307ClinicalTrials.gov
• Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma#811615ClinicalTrials.gov
• Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma#878908ClinicalTrials.gov
• Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma#991906ClinicalTrials.gov
• Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer#67904ClinicalTrials.gov
• Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy#801069ClinicalTrials.gov
• Impacted Tooth Management and Osteoradionecrosis Risk in NPC#810923ClinicalTrials.gov
• Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response#845838ClinicalTrials.gov
• Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher Immunotherapy#121364ClinicalTrials.gov
• KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma#873281ClinicalTrials.gov
• Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy#909211ClinicalTrials.gov
• SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC#321702ClinicalTrials.gov
• A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)#911096ClinicalTrials.gov
• Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients#844573ClinicalTrials.gov
• Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients#829614ClinicalTrials.gov
• Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors#907871ClinicalTrials.gov
• 68Ga-FAPI-46 PET/CT for the Prediction of Clinical Response to Neoadjuvant Therapy in Nasopharyngeal Carcinoma Patients#916213ClinicalTrials.gov